ASCO 2022 Conference Coverage

 

ASCO 2022 Conference Coverage
J

Lecture Summary - ASCO 2022 on a Phase I, Open-Label, Dose Escalation, Confirmation, and Expansion Trial of BI 1810631 as Monotherapy in Advanced/Metastatic Solid Tumors With HER2 Aberrations

By ASCO 2022 Conference Coverage FEATURING John Heymach
By ASCO 2022 Conference Coverage FEATURING John Heymach
14 views
June 16, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

03:15
Lilly Medical Affairs

Unmet Needs and Resistance Mechanisms in Patients With HR+, HER2- MB…

Feat. W. Mchayleh

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira
Lung
01:24

Lecture Summary - ASCO 2022 Five-Year Survival Outcomes From CheckMa…

ASCO 2022 Conference Coverage

L. Paz-Ares

97 views
10:59

ASCO 2022 Five-Year Survival Outcomes From CheckMate 227: Nivo + Ipi…

ASCO 2022 Conference Coverage

L. Paz-Ares

146 views
01:21

Lecture Summary - ASCO 2022 on the Phase 3 AcceleRET Lung Study: 1L …

ASCO 2022 Conference Coverage

F. de Marinis

27 views
12:27

ASCO 2022 on the Phase 3 AcceleRET Lung Study: 1L Pralsetinib in RET…

ASCO 2022 Conference Coverage

F. de Marinis

182 views
01:08

Lecture Summary - Pralsetinib in Patients (pts) With Advanced or Met…

ASCO 2022 Conference Coverage

L. Wirth

20 views
10:01

ASCO 2022 Updated Data From the ARROW Trial: Pralsetinib in Patients…

ASCO 2022 Conference Coverage

L. Wirth

158 views
01:46

Lecture Summary - ASCO 2022 3-Year Update From CheckMate 9LA: 1L Niv…

ASCO 2022 Conference Coverage

L. Paz-Ares

21 views
09:18

ASCO 2022 3-Year Update From CheckMate 9LA: 1L Nivo + Ipi + 2 Cycles…

ASCO 2022 Conference Coverage

L. Paz-Ares

477 views
26:58

ASCO 2022 Immunotherapy Nuances in Locally Advanced NSCLC

ASCO 2022 Conference Coverage

J. Varlotto

31 views
48

Lecture Summary - ASCO 2022 Immunotherapy Nuances in Locally Advance…

ASCO 2022 Conference Coverage

J. Varlotto

23 views
06:33

ASCO 2022 on Acquired EGFR-Resistant Mutations in NSCLC

ASCO 2022 Conference Coverage

L. Raez

275 views
55

Lecture Summary - ASCO 2022 on Acquired EGFR-Resistant Mutations in …

ASCO 2022 Conference Coverage

L. Raez

14 views
01:06

Lecture Summary - ASCO 2022 on Recurrent SCLC: Can We Change the Par…

ASCO 2022 Conference Coverage

R. Gentzler

16 views
01:28

Lecture Summary - ASCO 2022 on Durvalumab +/- Tremelimumab + Chemo i…

ASCO 2022 Conference Coverage

B. Chul Cho

14 views
07:37

ASCO 2022 on Durvalumab +/- Tremelimumab + Chemo in 1L mNSCLC: AE Ma…

ASCO 2022 Conference Coverage

B. Chul Cho

60 views
05:02

ASCO 2022 on IO and Chemo-IO for NSCLC With Novel Actionable Oncogen…

ASCO 2022 Conference Coverage

L. Mazzeo, M. Occhipinti

186 views
01:09

Lecture Summary - ASCO 2022 Impact of Trilaciclib on Multilineage Ch…

ASCO 2022 Conference Coverage

J. Goldschmidt

18 views
14:23

ASCO 2022 Impact of Trilaciclib on Multilineage Chemo-Induced Myelos…

ASCO 2022 Conference Coverage

J. Goldschmidt

92 views
04:31

ASCO 2022 Predictors of Biomarker Testing Among Pts With mNSCLC

ASCO 2022 Conference Coverage

N. Robert

691 views
06:43

ASCO 2022 on a Phase I, Open-Label, Dose Escalation, Confirmation, a…

ASCO 2022 Conference Coverage

J. Heymach

106 views
01:17

Lecture Summary - ASCO 2022 on a Phase I, Open-Label, Dose Escalatio…

ASCO 2022 Conference Coverage

J. Heymach

14 views
20:37

Taking on Goliath: Targeting KRAS in NSCLC

Jia Luo

1.2K views
07:03

ASCO 2022 on Phase 3 ATLANTIS Trial: Analysis of Patients With Relap…

ASCO 2022 Conference Coverage

A. Navarro

253 views
05:27

ASCO 2022 on Telisotuzumab Vedotin in Advanced c-Met Overexpressing …

ASCO 2022 Conference Coverage

R. Camidge

180 views
52

Lecture Summary - ASCO 2022 Analysis of Patients With Relapsed SCLC …

ASCO 2022 Conference Coverage

A. Navarro

23 views
23

Lecture Summary - ASCO 2022 on Telisotuzumab Vedotin in Advanced c-M…

ASCO 2022 Conference Coverage

R. Camidge

289 views
05:57

ASCO 2022 on TROPION-Lung08: Dato-DXd + Pembro in Treatment-Naïve Ad…

ASCO 2022 Conference Coverage

B. Levy

131 views
01:18

Lecture Summary - ASCO 2022 on ctDNA Shed as a Tool to Select Immune…

ASCO 2022 Conference Coverage

B. Besse

88 views
33

Lecture Summary - ASCO 2022 Combi-TED: A Multicenter Phase II Trial …

ASCO 2022 Conference Coverage

F. Cappuzzo

19 views
04:36

ASCO 2022 Combi-TED: A Multicenter Phase II Trial Evaluating Efficac…

ASCO 2022 Conference Coverage

F. Cappuzzo

64 views
01:01

Lecture Summary - ASCO 2022 on Stereotactic Radiosurgery vs. WBRT in…

ASCO 2022 Conference Coverage

K. Gaebe

47 views
15:49

ASCO 2022 on Stereotactic Radiosurgery vs. WBRT in SCLC and Intracra…

ASCO 2022 Conference Coverage

K. Gaebe

431 views
25

Lecture Summary - ASCO 2022 on KEYVIBE-008: Randomized, Phase 3 Stud…

ASCO 2022 Conference Coverage

J. Sands

43 views
04:05

ASCO 2022 on KEYVIBE-008: Randomized, Phase 3 Study of 1L Vibostolim…

ASCO 2022 Conference Coverage

J. Sands

510 views
24

Lecture Summary - ASCO 2022 on Clinical and Genomic Characteristics …

ASCO 2022 Conference Coverage

J. Sands

20 views
07:37

ASCO 2022 on Clinical and Genomic Characteristics of Pts With Durabl…

ASCO 2022 Conference Coverage

J. Sands

278 views
52

Lecture Summary - ASCO 2022 Three-Year Outcomes and Correlative Anal…

ASCO 2022 Conference Coverage

B. Ricciuti

114 views
07:54

ASCO 2022 Three-Year Outcomes and Correlative Analyses in Patients W…

ASCO 2022 Conference Coverage

B. Ricciuti

319 views
07:00

ASCO 2022 on GEOMETRY-N Trial: Neoadjuvant and Adjuvant Capmatinib i…

ASCO 2022 Conference Coverage

J. Lee

961 views